News
05-05-2010, 09:40 PM
C. R. Bard, Inc. today announced that it has reached a definitive agreement to acquire SenoRx, Inc. (Nasdaq: SENO), for a purchase price of $11.00 per share in cash, totaling approximately $200 million, net of cash acquired.
More... (http://www.news-medical.net/news/20100506/C-R-Bard-reaches-definitive-agreement-to-acquire-SenoRx.aspx)
More... (http://www.news-medical.net/news/20100506/C-R-Bard-reaches-definitive-agreement-to-acquire-SenoRx.aspx)